×
返回 Agenda
S08 : First-in-Global, First from Japan: Current Status and Future Prospects of First-In-Human Trials in Japan
Session Chair(s)
Masako Nakano, MD, PhD
Executive Medical Director, MORRIS Inc., Japan
Speaker(s)
Naruaki Imoto
, Pharmaceticals and Medical Devices Agency (PMDA), Japan
Mika Sato
Biomedical Research,Head of Translational Medicine Japan, Novartis Pharma K.K., Japan
Toshio Shimizu, MD, PhD
Professor, Department of New Experimental Therapeutics and Early Phase 1 Drug De, Kansai Medical University Hospital, Japan
Tatsuya Yoshihara
Deputy Director Clinical Research Center, SOUSEIKAI Fukuoka Mirai Hospital, Japan